Thrombin-inhibitor complexes in the blood during and after delivery

Thrombosis Research

Volumn 82, Issue 2, 1996, Pages 109-117

  Andersson, Terje ^a   Lorentzen, Bjørg ^a   Høgdahl, Heidi ^a   Clausen, Torun ^a   Mowinckel, Marie Christine ^a   Abildgaard, Ulrich ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

antithrombin; delivery; dermatan sulfate; heparin cofactor II; post partum period; thrombin

Indexed keywords

DERMATAN SULFATE; HEPARIN COFACTOR II; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; PRIORITY JOURNAL; THROMBOSIS;

EID: 0029932992     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00057-6     Document Type: Article

References (17)

1. DE BOER, K. TEN CATE, J.W. STURK, A. BORM, J.J.J. TREFFERS, P.E. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gyneco. 160, 95-100, 1989.
2. HALLIGAN, A. BONNAR, J. SHEPPARD, B. DARLING, M. WALSHE, J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol. 101, 488-492, 1994.
3. GERBASI, F.R. BOTTOMS, S. FARAG, A. MAMMEN, E.R. Changes in hemostasis activity during delivery and the immediate postpartum period. Am J Obstet Gynecol. 162, 1158-1163, 1990.
4. SALEH, A.A. STOWERS, M.A. ELDRIDGE, D.M. DOREY, L.G. HIROKAWA, S. DOMBORWKSI, M.P. BOTTOMS, S.F. COTTON, D.B. MAMMEN, E.R. Maternal and neonatal hemostatic correlation. Thromb Res. 68, 425-428, 1992.
5. ABILDGAARD, U. Binding of thrombin to antithrombin III. Scan J Clin Lab Invest. 24, 23-27, 1969.
6. TOLLEFSEN, D.M. PESTKA, C.A. MONAFO, W.J. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem. 258, 6713-6716, 1983.
7. REINTHALLER, A. MURSCH-EDLMAYR, G. TATRA, G. Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery. Br J Obstet Gynaecol. 90, 506-510, 1990.
8. LIU, L. BLAJCHMAN, M.A. ANDREW, M. GINSBERG, J. DEWAR, L. DELORME, M. OFOSU, F. A. Evidence for Heparin Cofactor II (HCII) as a physiological inhibitor of thrombin. Thromb Haemostas. 69, 899, 1993.
9. LIU, L. DEWAR, L. SONG, Y. KULCZYCKY, M. BLAJCHMAN, M.A. FENTONII, J.W. ANDREW, M. DELORME, M. GINSBERG, J. PREISSNER, K.T. OFOSU, F.A. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo. Thromb Haemostas. 73, 405-412, 1995.
10. ANDERSSON, T.R. SANDSET, P.M. NUSTAD, K. ABILDGAARD. U. Evidence that heparin cofactor II participates in the control of disseminated intravascular coagulation. Excerpta Medica International Congress Series 1993.
11. ANDREW, M. MITCHELL, L. BERRY, L. PAES, B. DELORME, M. OFOSU, F. BURROWS, R. KHAMBALIA, B. An anticoagulant dermatan sulfate proteoglycan circulated in the pregnant woman and her fetus. J Clin Invest. 89, 321-326, 1992.
12. ANDERSSON, T.R. SIE, P. PELZER, H. AAMODT, L-M. NUSTAD, K. ABILDGAARD, U. Elevated levels of thrombin-heparin cofactor II complex in plasma from patients with disseminated intravascular coagulation. Thromb Res. 66, 591-598, 1992.
13. DUPOUY, D. SIE, P. DOL, F. BONEU, B. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma. Thromb Haemostas. 60, 236-239, 1988.
14. ANDERSSON, T.R. Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation. Thromb Res. 46, 355-362, 1987.
15. McGUIRE, E.A., TOLLEFSEN, D.M. Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells. J Biol Chem. 262, 169-175, 1987.
16. PELZER, H. SCHWARZ, A. STUBER, W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemostas. 65, 153-159, 1991.
17. TEITEL, J.M. BAUER, K.A. LAU, H.K. ROSENBERG, R.D. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F1+2 fragment and thrombinantithrombin complex. Blood. 59, 1086-1097, 1982.